Angelo Paradiso
Clinical Experimental Oncology Laboratory
National Cancer Institute of Bari
Italy
Name/email consistency: high
- Altered p16INK4a and Fhit expression in carcinogenesis and progression of human oral cancer. Paradiso, A., Ranieri, G., Stea, B., Zito, A., Zehbe, I., Tommasino, M., Grammatica, L., De Lena, M. Int. J. Oncol. (2004)
- Topoisomerase-I, thymidylate synthase primary tumour expression and clinical efficacy of 5-FU/CPT-11 chemotherapy in advanced colorectal cancer patients. Paradiso, A., Xu, J., Mangia, A., Chiriatti, A., Simone, G., Zito, A., Montemurro, S., Giuliani, F., Maiello, E., Colucci, G. Int. J. Cancer (2004)
- Analysis of the reasons for accepting or declining participation in genetic research for breast cancer: a hospital-based population study. Paradiso, A., Bruno, M., Cicoria, O., Digennaro, M., Longo, S., Rinaldi, M., Schittulli, F. Tumori (2004)
- The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells. Paradiso, A., Cardone, R.A., Bellizzi, A., Bagorda, A., Guerra, L., Tommasino, M., Casavola, V., Reshkin, S.J. Breast Cancer Res. (2004)
- Quality control for biomarker determination in oncology: the experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT). Paradiso, A., Volpe, S., Iacobacci, A., Marubini, E., Verderio, P., Costa, A., Daidone, M.G., Marchetti, A., Mottolese, M., Amadori, D., De Paola, F., Saragoni, L., Medri, L., Nenci, I., Querzoli, P., Gion, M., Dittadi, R., Plebani, M., Orlando, C., Bevilacqua, G., Silvestrini, R. Int. J. Biol. Markers (2002)